The 2-Minute Rule for ABBV-744 in the treatment of drug-resistant cancers
As well as All those clinical trials described previously mentioned, there have also been pre-clinical studies that showed excellent effectiveness with regard to both of those safety and effectiveness versus AML.88 These preclinical studies present paradigms for future clinical trials in AML, and the use of novel combinations of drugs is previously